Credit Suisse’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $1.29M | Hold |
38,418
| – | – | ﹤0.01% | 2110 |
|
|
2023
Q4 | $1.24M | Sell |
38,418
-1,776
| -4% | -$57.4K | ﹤0.01% | 2190 |
|
|
2023
Q3 | $1.32M | Buy |
40,194
+1,615
| +4% | +$52.9K | ﹤0.01% | 2101 |
|
|
2023
Q2 | $1.36M | Buy |
38,579
+17,768
| +85% | +$625K | ﹤0.01% | 2164 |
|
|
2023
Q1 | $679K | Buy |
20,811
+480
| +2% | +$15.7K | ﹤0.01% | 2539 |
|
|
2022
Q4 | $1.12M | Sell |
20,331
-50
| -0.2% | -$2.76K | ﹤0.01% | 2248 |
|
|
2022
Q3 | $901K | Buy |
20,381
+2,319
| +13% | +$103K | ﹤0.01% | 2387 |
|
|
2022
Q2 | $880K | Buy |
18,062
+6,204
| +52% | +$302K | ﹤0.01% | 2464 |
|
|
2022
Q1 | $577K | Buy |
11,858
+1,367
| +13% | +$66.5K | ﹤0.01% | 2876 |
|
|
2021
Q4 | $447K | Buy |
10,491
+1,121
| +12% | +$47.8K | ﹤0.01% | 3100 |
|
|
2021
Q3 | $359K | Buy |
9,370
+157
| +2% | +$6.02K | ﹤0.01% | 3185 |
|
|
2021
Q2 | $260K | Buy |
+9,213
| New | +$260K | ﹤0.01% | 3335 |
|